These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 8889497

  • 1. Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid.
    Ou P, Nourooz-Zadeh J, Tritschler HJ, Wolff S.
    Free Radic Res; 1996 Oct; 25(4):337-46. PubMed ID: 8889497
    [Abstract] [Full Text] [Related]

  • 2. Spirohydantoin inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro.
    Jiang ZY, Zhou QL, Eaton JW, Koppenol WH, Hunt JV, Wolff SP.
    Biochem Pharmacol; 1991 Aug 22; 42(6):1273-8. PubMed ID: 1909528
    [Abstract] [Full Text] [Related]

  • 3. Studies on L-threose as substrate for aldose reductase: a possible role in preventing protein glycation.
    Devamanoharan PS, Varma SD.
    Mol Cell Biochem; 1996 Jun 21; 159(2):123-7. PubMed ID: 8858562
    [Abstract] [Full Text] [Related]

  • 4. Aldose reductase as dihydrodiol dehydrogenase. Naphthoquinone formation by rat lens aldose reductase.
    Sato S, Sugiyama K, Carper D.
    Adv Exp Med Biol; 1997 Jun 21; 414():499-505. PubMed ID: 9059655
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A, Diecke FP, Mistry K, Cruz E.
    Pharmacology; 1997 Feb 21; 54(2):76-83. PubMed ID: 9088040
    [Abstract] [Full Text] [Related]

  • 6. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM, González RG.
    Metabolism; 1986 Apr 21; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study.
    Obrosova IG, Fathallah L.
    Diabetologia; 2000 Aug 21; 43(8):1048-55. PubMed ID: 10990083
    [Abstract] [Full Text] [Related]

  • 8. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF, Lee JW, Fujisawa S, Blessing K, Lou MF.
    J Ocul Pharmacol Ther; 2000 Apr 21; 16(2):149-60. PubMed ID: 10803425
    [Abstract] [Full Text] [Related]

  • 9. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
    Gonzalez AM, Sochor M, Hothersall JS, McLean P.
    Diabetes; 1986 Nov 21; 35(11):1200-5. PubMed ID: 3093302
    [Abstract] [Full Text] [Related]

  • 10. Activation of aldose reductase from human tissues.
    Das B, Srivastava SK.
    Diabetes; 1985 Nov 21; 34(11):1145-51. PubMed ID: 3930326
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
    Lou MF, Xu GT, Zigler S, York B.
    Curr Eye Res; 1996 Apr 21; 15(4):423-32. PubMed ID: 8670742
    [Abstract] [Full Text] [Related]

  • 12. [Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes].
    Kuchmerovskaia TM, Donchenko GV, Klimenko AP, Chichkovskaia GV, Pakirbaeva LV, Kozitskiĭ ZIa, Efimov AS.
    Ukr Biokhim Zh (1978); 1997 Apr 21; 69(3):77-82. PubMed ID: 9505366
    [Abstract] [Full Text] [Related]

  • 13. Aldose reductase: a window to the treatment of diabetic complications?
    Crabbe MJ, Goode D.
    Prog Retin Eye Res; 1998 Jul 21; 17(3):313-83. PubMed ID: 9695797
    [Abstract] [Full Text] [Related]

  • 14. Oxidized aldose reductase: in vivo factor not in vitro artifact.
    Grimshaw CE, Lai CJ.
    Arch Biochem Biophys; 1996 Mar 01; 327(1):89-97. PubMed ID: 8615700
    [Abstract] [Full Text] [Related]

  • 15. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK, Hair GA, Das B.
    Proc Natl Acad Sci U S A; 1985 Nov 01; 82(21):7222-6. PubMed ID: 3933003
    [Abstract] [Full Text] [Related]

  • 16. Residues affecting the catalysis and inhibition of rat lens aldose reductase.
    Carper DA, Hohman TC, Old SE.
    Biochim Biophys Acta; 1995 Jan 05; 1246(1):67-73. PubMed ID: 7811733
    [Abstract] [Full Text] [Related]

  • 17. Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors.
    Sato S, Sugiyama K, Lee YS, Kador PF.
    Exp Eye Res; 1999 May 05; 68(5):601-8. PubMed ID: 10328974
    [Abstract] [Full Text] [Related]

  • 18. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.
    Saraswat M, Muthenna P, Suryanarayana P, Petrash JM, Reddy GB.
    Asia Pac J Clin Nutr; 2008 May 05; 17(4):558-65. PubMed ID: 19114390
    [Abstract] [Full Text] [Related]

  • 19. Determination of aldose reductase activity in the eye by localized magnetic resonance spectroscopy.
    Lizak MJ, Mori K, Kador PF.
    J Ocul Pharmacol Ther; 2001 Oct 05; 17(5):475-83. PubMed ID: 11765152
    [Abstract] [Full Text] [Related]

  • 20. Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats.
    Griffin BW, McNatt LG, Chandler ML, York BM.
    Metabolism; 1987 May 05; 36(5):486-90. PubMed ID: 3106757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.